Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04822844
Other study ID # HSC-SN-20-1306
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date June 30, 2021

Study information

Verified date June 2021
Source The University of Texas Health Science Center, Houston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a quality improvement project that aims to assess the effect of nurse-driven administration of essential oil aromatherapy on postoperative nausea and vomiting (PONV) in patients while in the post-anesthesia care unit (PACU) after general anesthesia.


Description:

In this three-month quality improvement project, nurse-driven aromatherapy will be offered to all patients in the main PACU setting at the Hospital Corporation of America (HCA) Houston Healthcare Southeast Hospital after they have undergone surgical procedures with general anesthesia, with the exception of patients who report allergies or sensitivity to ginger or lavender essential oils (EO) and patients who wish to be excluded from the project.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date June 30, 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - PACU patients who are in the main PACU setting at HCA Houston Healthcare Southeast Hospital after having undergone general anesthesia for a surgical procedure Exclusion Criteria: - patients with allergies or sensitivity to ginger or lavender essential oils - patients who wish to be excluded from the project

Study Design


Related Conditions & MeSH terms

  • Nausea
  • Postoperative Nausea and Vomiting
  • Postoperative Nausea and Vomiting (PONV)
  • Vomiting

Intervention

Other:
Lavender Essential Oil
Within 5 minutes of arrival at the PACU, the PACU nurse will proactively offer the patient a 2x2 gauze with two drops of essential oil (patient's choice of ginger or lavender essential oil) for all patients who have opted to participate, regardless of their nausea and vomiting status. Participating patients will continue to use the essential oil during their stay in the PACU, which is typically 45-60 minutes.
Ginger Essential Oil
Within 5 minutes of arrival at the PACU, the PACU nurse will proactively offer the patient a 2x2 gauze with two drops of essential oil (patient's choice of ginger or lavender essential oil) for all patients who have opted to participate, regardless of their nausea and vomiting status. Participating patients will continue to use the essential oil during their stay in the PACU, which is typically 45-60 minutes.

Locations

Country Name City State
United States HCA Houston Healthcare Southeast Hospital Pasadena Texas

Sponsors (2)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston HCA Houston Healthcare Southeast Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Post-Operative Nausea and Vomiting Episodes While in the PACU during stay in PACU (about 45-60 minutes)
Secondary PACU Length of Stay PACU length of stay is the time between PACU admission and PACU discharge, measured in minutes. time between PACU admission and PACU discharge (about 45-60 minutes)
Secondary Number of Participants Who Use Antiemetics While in the PACU during stay in PACU (about 45-60 minutes)
Secondary Patient Satisfaction as Assessed by the Press Ganey Patient Satisfaction Survey The Press Ganey Patient Satisfaction Survey is scored from 0 to 100, with a higher score indicating greater satisfaction. at discharge (about 1 hour after PACU admission)
See also
  Status Clinical Trial Phase
Completed NCT04557189 - A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery Phase 2
Completed NCT01474915 - Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting Phase 4